INFORMAF II—Phase 1 pilot randomised controlled trial evaluating the effect of an atrial fibrillation digital education programme: study protocol

Author:

Ferguson Caleb12,Allida Sabine12,William Scott12,Downie Annie3,Wilson Tonia3,John Reejamol12,McDonagh Julee12ORCID,Lababedi Judith4,Bajorek Beata5,Hickman Louise2,Wynne Rochelle67

Affiliation:

1. Centre for Chronic & Complex Care Research, Blacktown Hospital Western Sydney Local Health District Blacktown New South Wales Australia

2. School of Nursing University of Wollongong Wollongong New South Wales Australia

3. Sutherland Hospital South East Sydney Local Health District Caringbah New South Wales Australia

4. Lived Experience Consumer Sydney New South Wales Australia

5. Hunter Medical Research Institute Newcastle New South Wales Australia

6. School of Nursing & Midwifery, Centre for Quality & Patient Safety in the Institute for Health Transformation Deakin University Burwood Victoria Australia

7. Western Health Partnership St Albans Victoria Australia

Abstract

AbstractAimTo evaluate the effect of a novel, co‐designed, digital AF educational program, ‘INFORM‐AF’, to reduce re‐hospitalisation of people with AF.The secondary aims are to examine the effect of the intervention on: (a) reducing cardiovascular‐related hospitalisation, (b) increasing medication adherence, AF‐related knowledge, and Atrial fibrillation (AF)‐related quality of life and (c) determining the cost‐effectiveness of the intervention.BackgroundAF is an increasingly prevalent cardiac arrythmia that involves complex clinical management. Comprehensive education is essential for successful self‐management of AF and is associated with positive health‐related outcomes. There has been an increase in technology‐based education for AF. However, its effects on hospitalisation, medication adherence and patient‐reported outcomes are unclear.DesignA prospective, randomised (1:1), open‐label, blinded‐endpoint, multicentre clinical trial.MethodsEligible participants are aged 18 years or above, diagnosed with AF, and own a smartphone. The study will be conducted at two metropolitan hospitals. In the intervention group, participants will receive the AF educational program delivered via Qstream®. In the control group, participants will receive the Stroke Foundation ‘Living with AF’ booklet. The primary outcome is re‐hospitalisation within 12 months from an indexed presentation or hospital admission.ConclusionThis clinical trial is part of a developing program of work that will examine mHealth educational‐behavioural interventions on cardiovascular outcomes. Findings from this pilot study will inform the development of a digital educational framework for patients living with AF.Implications for the Profession and/or Patient CareThere remain many gaps in providing high‐quality patient education for patients with AF. This trial will test a new theory‐driven, smartphone‐based education program on important clinical outcomes, including rehospitalisation.Impact This study evaluates a novel, co‐designed, digital AF educational program, ‘INFORM‐AF’, to reduce the re‐hospitalisation of people with AF. Study results are expected to be reported in 2025. Findings are expected to inform practice recommendations for AF patient education that may be included in future clinical practice guideline recommendations. Reporting MethodSPIRIT Checklist.Patient or Publication ContributionJL is a consumer co‐researcher on the project and provided critical input into intervention design, and feedback and input across the study duration.

Publisher

Wiley

Reference21 articles.

1. Australian Clinical Trials Alliance. (2018).Consumer involvement consultation report.www.clinicaltrialsalliance.org.au/resource/acta‐consumer‐involvement‐consultationreport‐2/

2. Australian Clinical Trials Alliance. (2019).Toolkit for researchers and research organisations. Retrieved 26/07/2023 fromwww.involvementtoolkit.clinicaltrialsalliance.org.au/toolkit

3. Estimating the current and future prevalence of atrial fibrillation in the Australian adult population;Ball J.;Medical Journal of Australia,2015

4. Antithrombotic therapy in the prevention of stroke;Bir S.;Biomedicine,2021

5. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation;Charlson M. E.;Journal of Chronic Diseases,1987

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3